Log in or Sign up for Free to view tailored content for your specialty!
Lupus News
Childhood lupus remission definitions emphasize corticosteroid cessation
New definitions of remission specific to childhood systemic lupus erythematosus promote cessation of corticosteroids and could enable combined child-adult treat-to-target studies, according to an analysis published in Clinical Immunology.
VIDEO: Sunscreen paramount in reducing cutaneous lupus effects
CLEVELAND — While new treatments for cutaneous lupus are on the horizon, sunscreen remains the best way to offset effects, according to J. Michelle Kahlenberg, MD, PhD.
Log in or Sign up for Free to view tailored content for your specialty!
Lupus erythematosus skin disease does not impact severity of systemic lupus
Skin disease manifestations in systemic lupus erythematosus do not have an impact on disease severity, according to a study.
Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis
Proteinuria levels are not predictive of membranous lupus nephritis vs. proliferative lupus nephritis, according to data published in Rheumatology.
Simplified lupus infection prediction score more accurate, feasible than previous version
The SLE Severe Infection Score-Revised, an updated score for predicting severe infections in systemic lupus erythematosus, is more accurate and feasible than the prior version, according to data published in Lupus Science & Medicine.
Racing modified cells against each other in humans may be the next step in gene therapies
The next evolution of gene therapies may involve pitting T cells with different modifications against one another in a “race” inside a human to determine which edits produce the best results against a tumor, an expert panel predicted.
FDA approves Benlysta autoinjector for at-home use in children with lupus
The FDA has approved a Benlysta autoinjector for children aged 5 years and older with systemic lupus erythematosus, enabling at-home administration for the first time, according to a press release from the manufacturer.
'Choose wisely': Each biologic for lupus has 'ideal patient profile'
DESTIN, Fla. — When choosing between biologic drugs for systemic lupus erythematosus, it is important to know the “ideal patient profile” each is best suited for, according to a speaker at the Congress of Clinical Rheumatology East.
'Quelling anxiety' essential for rheumatologists ensuring safe pregnancies
DESTIN, Fla. — Ongoing, frank discussions about reproductive health with patients of childbearing age is critical to safe pregnancy outcomes, according to a presenter at the Congress of Clinical Rheumatology East.
CAR T-cell therapy remains the 'hottest story' in lupus, autoimmune disease
DESTIN, Fla. — Positive results for chimeric antigen receptor T-cell therapy in systemic sclerosis and myositis have added fuel to the fire of recent landmark data in lupus, said a speaker at the Congress of Clinical Rheumatology East.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read